Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Day One Biopharmaceuticals, Inc./ 10-K/A

SEC Filing · 10-K/A

Day One Biopharmaceuticals, Inc.

SEC Filing

Filed Apr 17, 2026Accepted Apr 17, 2026, 4:00 PM EDTCIK 1845337Accession 0001193125-26-161471
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
DAWNNASDAQ · EQUITY · Historical · closed Apr 22, 2026

Recent company filings

  1. SCHEDULE 13G/A - filed by Vestal Point Capital, LP regarding Day One Biopharmaceuticals, Inc.May 15, 2026
  2. 15-12G filingMay 4, 2026
  3. 4 filingApr 23, 2026
  4. 4 filingApr 23, 2026
  5. 4 filingApr 23, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗